Seeking Alpha

japalm

japalm
Send Message
View as an RSS Feed
View japalm's Comments BY TICKER:
Latest  |  Highest rated
  • Gilead Sciences beats by $0.56, beats on revenue [View news story]
    Very, very impressive!
    Jul 23 04:17 PM | 2 Likes Like |Link to Comment
  • Galena Biopharma: Numerous Red Flags Suggest A Significant Overvaluation [View article]
    Hi all,

    I invested in GALE not so much for the possibilities NeuVax, but because I have seen what Subsys has done for Insys Therapeutics' stock over the course of the last 6 months or so and what this could mean for Galena IF their competitor drug Abstral is a success. And I wonder why it wouldn't be, if for the simple fact that some patients may prefer a pill form over the spray delivery system offered by Subsys? If I purchased GALE at $2 and the stock goes to $12, shouldn't I be thrilled? But what happens if Abstral does very well and strong sales drive the stock price even higher than that? I'd be even more excited. Is this way of thinking wrong? I really am looking for feedback here.
    Feb 2 01:17 PM | 2 Likes Like |Link to Comment
  • Small-cap biotechs scorched [View news story]
    I am long GALE and expect their Abstral sales to be stronger than expected and really drive up the company's value (and stock price) when they are announced sometime in March.
    Jan 28 01:03 AM | Likes Like |Link to Comment
  • Galena Biopharma -6.4% as Jim Cramer says take profits [View news story]
    Thanks for pointing out forthcoming Abstral sales...that's important and seems to be missing in the chatter on this exciting company
    Jan 20 03:16 AM | 1 Like Like |Link to Comment
  • Should You Sell Gilead Sciences After A Successful 2013? [View article]
    Can you please explain what you mean by "ready for distribution?" Thanks.
    Jan 11 01:17 PM | Likes Like |Link to Comment
COMMENTS STATS
5 Comments
5 Likes